Vystar to Produce RxAir400 UV-C Light Air Purifiers with New Manufacturer CDC reports UV-C Light Germicidal Irradiation (UVGI) as one of “most promising methods" for Coronavirus decontamination of facemasks.1 RxAir400 employs powerful UVGI proven to inactivate >99.9% of...

Vystar Resumes Production of FDA Certified Rx3000 UV Light Air Purifiers for Use in Healthcare Facilities Rx3000® UV Light Air Purifier production shifts to Massachusetts to ensure quality, fast production & delivery Rx3000 inactivates on first pass 99.97% of harmful airborne viruses & bacteria. ...

Vystar to Resume Production of Rx3000 UV Light Air Purifiers for Use in Hospitals, Healthcare Facilities Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria.Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other...

Vystar Acquires Assets of UV Flu Technologies UV Flu Technologies Air Purifiers Destroy Viruses and BacteriaPurchase creates additional Vystar revenue stream WORCESTER, Mass., May 10, 2018 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCPink:VYST)...